Nexalin is offering 2,315,000 shares of common stock at $4.15 per share. Nexalin will trade under the ticker name “NXL,” according to the Sept. 15 company news release.
Trading for Nexalin on the Nasdaq is set to begin Sept. 20.
Nexalin goes public with $9.6M offering
Mental health neurostimulation company Nexalin is going public with a $9.6 million initial public offering.
